Skip to main content
Gary Dahl, MD, Pediatric Hematology & Oncology, Palo Alto, CA

GaryDahlMD

Pediatric Hematology & Oncology Palo Alto, CA

Cancer Genetics/Cancer Risk Assessment

Professor, Pediatrics - Hematology & Oncology, Stanford University Medical Center

Dr. Dahl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dahl's full profile

Already have an account?

  • Office

    725 Welch Rd
    300
    Palo Alto, CA 94304
    Phone+1 650-497-8000

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology, 1973 - 1976
  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1972 - 1974
  • Oregon Health  Science University Hospital
    Oregon Health Science University HospitalInternship, Transitional Year, 1967 - 1968
  • Oregon Health and Science University School of Medicine
    Oregon Health and Science University School of MedicineClass of 1967

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1968 - Present
  • CA State Medical License
    CA State Medical License 1986 - 2026
  • TN State Medical License
    TN State Medical License 1974 - 1987
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Clara Mason: Humble Pioneer
    Clara Mason: Humble PioneerOctober 30th, 2020
  • Parental Smoking Linked to Genetic Changes Found in Childhood Cancer
    Parental Smoking Linked to Genetic Changes Found in Childhood CancerApril 3rd, 2017
  • A Germ-Line Deletion of APOBEC3B Does Not Contribute to Subtype-Specific Childhood Acute Lymphoblastic Leukemia Etiology
    A Germ-Line Deletion of APOBEC3B Does Not Contribute to Subtype-Specific Childhood Acute Lymphoblastic Leukemia EtiologyJanuary 1st, 2018